Johnson & Johnson Timeline

Events

• 2026-07-28 - Deployment - Cleveland Clinic Abu Dhabi completes Middle East's first MONARCH robotic bronchoscopy - MONARCH guides a flexible endoscope through the lung airways to biopsy small, hard-to-reach nodules. The completed procedure establishes clinical use at Cleveland Clinic Abu Dhabi. The hospital used the platform to support continuous-vision navigation and… - source: gulfnews.com
• 2026-07-22 - Regulatory - OTTAVA receives US FDA De Novo authorization - Authorization covers multiple upper-abdominal general-surgery procedures. OTTAVA coordinates four table-integrated robotic arms with synchronized table motion. A 30-patient pivotal gastric-bypass study completed every procedure robotically without conversion. - source: jnjmedtech.com
• 2026-01-07 - Regulatory - Johnson & Johnson submits OTTAVA robotic surgical system to FDA - Johnson & Johnson MedTech submitted the OTTAVA robotic surgical system to the U.S. FDA. The submission was supported by data from the system's investigational device exemption study. The event marks a regulatory milestone after first clinical cases were… - source: jnj.com
• 2025-04-14 - Capability - Johnson & Johnson MedTech completes first clinical cases with OTTAVA surgical robot - Johnson & Johnson MedTech completed the first cases in the clinical trial for the OTTAVA robotic surgical system. The first procedure was a Roux-en-Y gastric bypass at Memorial Hermann-Texas Medical Center. The milestone moves OTTAVA from platform… - source: jnj.com
• 2025-03-12 - Regulatory - FDA clears MONARCH QUEST robotic-bronchoscopy upgrade - MONARCH QUEST adds enhanced AI navigation and a verified interface for GE HealthCare’s OEC 3D mobile cone-beam CT imaging system. Its NVIDIA RTX accelerated computing stack increases real-time computational power by 260% for navigation algorithms. The update… - source: jnjmedtech.com
• 2024-11-13 - Regulatory - Johnson & Johnson receives FDA IDE approval for OTTAVA robotic surgical system - Johnson & Johnson MedTech received FDA investigational device exemption approval for OTTAVA. The approval allowed the company to begin a U.S. clinical trial of the robotic surgical system. The milestone preceded the first completed OTTAVA cases and later FDA… - source: medthority.com
• 2019-12-20 - Acquisition - Johnson & Johnson agrees to acquire Verily's Verb Surgical stake - The transaction covered Verily's remaining stake after the companies' multi-year surgical-robotics collaboration. Johnson & Johnson expected the acquisition to close in the first half of 2020, subject to antitrust clearance and customary conditions. - source: jnj.com
• 2015-12-10 - Partnership - Johnson & Johnson and Verily form Verb Surgical - Johnson & Johnson announced Verb Surgical's formation on December 10, 2015, following an earlier Ethicon-Google Life Sciences collaboration. Ethicon and Verily contributed intellectual property, in-process research assets and operating expertise to the new… - source: jnj.com